Ulrich Neumann

Ulrich Neumann (LinkedIn username: uneumann) is a healthcare and pharmaceutical industry professional with extensive experience in market access and health economics.1 2 He currently serves as Director for Market Access Scientific and External Strategy at Janssen, the Pharmaceutical Companies of Johnson & Johnson.1 In this role, he is part of a senior team developing models and evidence generation for health economic policy evaluations, focusing on areas such as value assessment methodologies, healthcare financing, and value-based insurance design.1

Neumann's educational background is diverse and comprehensive:

MBA from Imperial College London
MSc from the London School of Economics
MA from the University of Southern California (Annenberg School and Marshall School of Business)
BSc in Public Administration
BA in Multi-level Governance1

Prior to his current position, Neumann worked at Certara, a drug development platform, and Analytica Laser, a population health intelligence consultancy.1 He is also an author, having published two books and various articles, whitepapers, reports, and posters on pharmaceutical policy and managed care topics.1

Neumann is active in industry events and discussions, as evidenced by his LinkedIn posts about healthcare innovation and pharmaceutical development.3 4